Related Experiment Video
Updated: Aug 8, 2026
06:46
Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Idiopathic gastric acid hypersecretion. Comparison with Zollinger-Ellison syndrome
1Department of Medicine, Loma Linda University Medical Center, California.
Digestive Diseases and Sciences
|July 1, 1994
Summary
Idiopathic gastric acid hypersecretion and Zollinger-Ellison syndrome share some symptoms but differ significantly in serum gastrin levels and basal acid output. Differentiating these conditions is crucial for appropriate patient management and treatment strategies.
Area of Science:
- Gastroenterology
- Endocrinology
- Internal Medicine
Background:
- Acid-peptic diseases often present with gastric acid hypersecretion.
- Idiopathic gastric acid hypersecretion (I-GAH) and Zollinger-Ellison syndrome (ZES) can have overlapping clinical features, including high basal acid output.
- Accurate differentiation is vital due to distinct treatment and natural histories.
Purpose of the Study:
- To compare key clinical and biochemical parameters between patients with I-GAH and ZES.
- To identify distinguishing features that aid in differentiating these two hypersecretory states.
Main Methods:
- A comparative study involving 124 patients diagnosed with I-GAH and 137 patients with ZES.
- Analysis of demographic data, symptom presentation, medical history, serum gastrin levels, and basal acid output.
Main Results:
- Significant differences observed in mean serum gastrin (60 pg/ml in I-GAH vs. 3679 pg/ml in ZES) and mean basal acid output (15.4 meq/hr in I-GAH vs. 47.0 meq/hr in ZES).
- Patients with ZES were older at symptom onset (41 vs. 33 years) and had shorter symptom duration before diagnosis (5 vs. 11 years).
- Higher prevalence of diarrhea (75% vs. 12%) and duodenal ulcers (74% vs. 53%) in ZES patients compared to I-GAH patients.
Conclusions:
- Serum gastrin levels and basal acid output are critical differentiating markers between I-GAH and ZES.
- Clinical presentation, including symptom duration and prevalence of diarrhea and duodenal ulcers, also aids in distinguishing these conditions.
- Accurate diagnosis ensures appropriate therapeutic interventions for patients with gastric acid hypersecretion.
More Related Videos
Related Concept Videos
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
01:17Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:30Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:25Peptic Ulcer Disease I: Introduction
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...